检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:宋宙光[1] SONG Zhouguang(Shanxi Provincial Eye Hospital,Taiyuan 030002,China)
机构地区:[1]山西省眼科医院,太原030002
出 处:《中国中医眼科杂志》2021年第2期123-126,136,共5页China Journal of Chinese Ophthalmology
摘 要:糖尿病视网膜病变(DR)增殖期玻璃体切割手术后如果反复出现玻璃体腔内积血,无论中医还是西医,治疗棘手,预后差。掌握该时期的根本病机,既是该病防治的难点,也是突破口。古之消渴与今之糖尿病存在诸多不同之处,前者以主观的症状为主要诊断依据,而后者以客观的实验室血糖指标为主要诊断依据。随着诸多学者对糖尿病的发病机制认识的突破,DR增殖期的发病机制——“阴损及阳”也逐渐得到广泛认可,尤其是总结出阳虚可能是DR从非增殖期转化为增殖期的关键病机,亦可能是DR增殖期病变发生的始动因素。因此,本文从“阳不统血”理论出发,以理论阐述和病案发挥的形式,探讨“阳不统血”理论在增殖期DR玻璃体切割术后玻璃体腔内再积血治疗中的指导作用。It is difficult to treat repeatedly vitreous hemorrhage after vitrectomy in proliferative diabetic retinopathy case,and its prognosis is poor,for both Traditional Chinese Medicine and Western Medicine.How to understand the basic pathogenesis of this period is both the difficult point and the breakthrough point of the disease prevention and treatment.There are many differences between wasting-thirst(Xiaoke)and diabetes,the former is based on subjective symptoms,while the latter is based on objective laboratory blood glucose indexes.At present,with the breakthrough of many scholars'understandings of the pathogenesis of diabetes,detriment to yin affecting yang in the proliferative stage of diabetic retinopathy is gradually widely recognized.In particular,it is concluded that yang deficiency may be the key pathogenesis of the transformation from non-proliferative phase to proliferative phase,and may also be the initiating factor of the occurrence of proliferative phase.Therefore,this paper starts from the theory of yang failing to control blood theory,and discusses the guiding role of yang failing to control blood theory in the treatment of vitreous hemorrhage after vitrectomy in proliferative diabetic retinopathy cases in the form of theoretical explanation and medical records.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3